Discovery Spotlight: Landmark stem cells trial at Doernbecher yields positive results
July 19, 2009
A groundbreaking clinical trial to test the safety and preliminary efficacy of StemCells, Inc.’s proprietary HuCNS-SC® product candidate in children with a rare neurodegenerative disease has yielded a favorable safety profile of the product and ...
Landmark Stem Cells Trial Yields Positive Results
June 08, 2009
"The OHSU Doernbecher research team worked very hard to carry out this highly complex research and is heartened to see that this approach appears to be safe. We are delighted that this first trial of human neural stem cells was successful and offers ...
New Milestone In Doernbecher Stem Cells Trial
June 19, 2007
StemCells, Inc. (NASDAQ: STEM) today announced the Phase I clinical trial of its proprietary HuCNS-SC™ product candidate (purified human neural stem cells) has successfully completed enrollment of the low-dose cohort and will proceed to the high-dose ...
Doernbecher Children's Hospital Team Completes First-Ever Stem Cell Transplant In Human Brain
November 16, 2006
Portland, Ore. Neurosurgeons and physicians at Doernbecher Children's Hospital, Oregon Health Nathan Selden, M.D., Ph.D., F.A.C.S., F.A.A.P., Campagna Associate Professor of Pediatric Neurological Surgery and Head of the Division of Pediatric ...
Doernbecher Researchers To Study Effectiveness Of Stem Cell Transplant In Human Brain
March 09, 2006
Researchers in Doernbecher Children's Hospital at Oregon Health & Science University will begin a Phase I clinical trial using stem cells in infants and children with a rare neurodegenerative disorder that affects infants and children. The ...
